Clinical Trial Update: Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of valproic acid and methylprednisolone for treatment of acute graft-versus-host disease in patients rece…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Peripheral Blood Stem Cell Transplantation, aGVHD | Phase 2 | Status: UNKNOWN